| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Sorafenib | CCLE | pan-cancer | AAC | -0.015 | 0.8 |
| mRNA | navitoclax:piperlongumine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | UNC0638 | GDSC1000 | pan-cancer | AAC | 0.0093 | 0.8 |
| mRNA | BRD-K44224150 | CTRPv2 | pan-cancer | AAC | -0.024 | 0.8 |
| mRNA | erismodegib | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | JNJ-26854165 | CTRPv2 | pan-cancer | AAC | 0.01 | 0.8 |
| mRNA | WZ-1-84 | GDSC1000 | pan-cancer | AAC | 0.015 | 0.8 |
| mRNA | masitinib | GDSC1000 | pan-cancer | AAC | -0.0098 | 0.8 |
| mRNA | ELCPK | CTRPv2 | pan-cancer | AAC | -0.015 | 0.8 |
| mRNA | AZD0530 | CCLE | pan-cancer | AAC | 0.014 | 0.8 |